Lippert J, Appenzeller S, Liang R, Sbiera S, Kircher S, Altieri B, Nanda I, Weigand I, Gehrig A, Steinhauer S, Riemens R.J.M, Rosenwald A, Müller C.R, Kroiss M, Rost S, Fassnacht M, Ronchi C.L (2018) Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication. J Clin Endocrinol Metab. Dec 1;103(12):4511-4523. doi: 10.1210/jc.2018-01348.
Henning J.E.K, Deutschbein T, Altieri B, Steinhauer S, Kircher S, Sbiera S, Wild V, Schlötelburg W, Kroiss M, Perotti P, Rosenwald A, Berruti A, Fassnacht M, Ronchi C.L (2017) Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors.J Clin Endocrinol Metab. 102:4323-4332
Altieri B, Sbiera S, Della Casa S, Weigand I, Wild V, Steinhauer S, Fadda G, Kocot A, Bekteshi M, Mambretti EM, Rosenwald A, Pontecorvi A, Fassnacht M, Ronchi C.L. (2016) Livin/BIRC7 expression as malignancy marker in adrenocortical tumors. Oncotarget. 8:9323-9338
Ronchi C.L, Peverelli E, Herterich S, Weigand I, Mantovani G, Schwarzmayr T, Sbiera S, Allolio B, Honegger J, Appenzeller S, Lania AG, Reincke M, Calebiro D, Spada A, Buchfelder M, Flitsch J, Strom TM, Fassnacht M (2016) Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas. Eur J Endocrinol. 2016: 174, 363-372
Ronchi C.L, Di Dalmazi G, Faillot S, Sbiera S, Assié G, Weigand I, Calebiro D, Schwarzmayr T, Appenzeller S, Rubin B, Waldmann J, Scaroni C, Bartsch DK, Mantero F, Mannelli M, Kastelan D, Chiodini I, Bertherat J, Reincke M, Strom TM, Fassnacht M, Beuschlein F on behalf of ENSAT (2016). Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation. J Clin Endocrinol Metab. 7, jc20161586
Calebiro D, Grassi ES, Eszlinger M, Ronchi C.L, Godbole A, Bathon K, Guizzardi F, de Filippis T, Krohn K, Jaeschke H, Schwarzmayr T, Bircan R, Gozu HI, Sancak S, Niedziela M, Strom TM, Fassnacht M, Persani L, Paschke R. (2016) Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas. J Clin Invest. 126, 3383-3388
Ronchi C.L, Sbiera S, Altieri B, Steinhauer S, Wild V, Bekteshi M, Kroiss M, Fassnacht M, Allolio B. (2015) Notch1 pathway in adrenocortical carcinomas: correlation with clinical outcome. Endocr Relat Cancer. 22, 531-543
Libé R, Borget I, Ronchi C.L, Zaggia B, Kroiss M, Kerkhofs T, Bertherat J, Volante M, Quinkler M, Chabre O, Bala M, Tabarin A, Beuschlein F, Vezzosi D, Deutschbein T, Borson-Chazot F, Hermsen I, Stell A, Fottner C, Leboulleux S, Hahner S, Mannelli M, Berruti A, Haak H, Terzolo M, Fassnacht M, Baudin E; ENSAT network. (2015) Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. Ann Oncol. 26, 2119-2125
Fassnacht M, Berruti A, Baudin E, Demeure MJ, Gilbert J, Haak H, Kroiss M, Quinn DI, Hesseltine E, Ronchi C.L, Terzolo M, Choueiri TK, Poondru S, Fleege T, Rorig R, Chen J, Stephens AW, Worden F, Hammer GD. (2015) Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study. Lancet Oncol. 16, 426-435
Beuschlein F., Fassnacht M., Assié G., Calebiro D., Stratakis C.A., Osswald A., Ronchi C.L, Wieland T., Sbiera S., Fausz F., Schaak K., Walther A., Schwarzmayr T., Barreau B., Vezzosi D., Rizk-Rabbin M., Szarek E., Salpea P., Forlino A., Vetro A., Zuffardi O., Kisker C., Diener S., Meitinger T., J. Lohse M.J., Reincke M., Bertherat J., Strom T.M., Allolio B. (2014) Germline and somatic gain of function of the main catalytic subunit of the cyclic AMP-dependent protein kinase causes corticotropin-independent Cushing’s syndrome. New Engl J Med 370, 1019-28
For a full list of Dr C.L Ronchi's publications
View all publications in research portal